Edit |   |
---|---|
Antigenic Specificity | FLT3 (Emirodatamab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | human |
Isotype | n/a |
Format | Protein A purified |
Size | 100 µg, 1 mg, |
Concentration | 1 mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Emirodatamab is a Chimeric Humanized monoclonal antibody targeting FLT3, expressed in Mammalian cells. |
Immunogen | n/a |
Other Names | Emirodatamab, Bispecific, FLT3, Stem cell tyrosine kinase 1, Fetal liver kinase-2, STK-1, STK1, FLK2, CD135, Receptor-type tyrosine-protein kinase FLT3, Fms-like tyrosine kinase 3, FL cytokine receptor, FLK-2, FLT-3, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
Gene, Accession # | UniProt: P36888, P07766 |
Catalog # | abx831816 |
Price | please inquire |
Order / More Info | FLT3 (Emirodatamab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950